Ingle JN - Search Results

1

Anastrozole Regulates Fatty Acid Synthase in Breast Cancer.

Cairns J, Ingle JN, Kalari KR, Goetz MP, Weinshilboum RM, Gao H, Li H, Bari MG, Wang L. Cairns J, et al. Among authors: ingle jn. Mol Cancer Ther. 2022 Jan;21(1):206-216. doi: 10.1158/1535-7163.MCT-21-0509. Epub 2021 Oct 19. Mol Cancer Ther. 2022. PMID: 34667110 Free PMC article.

2

Estrogen as therapy for breast cancer.

Ingle JN. Ingle JN. Breast Cancer Res. 2002;4(4):133-6. doi: 10.1186/bcr436. Epub 2002 May 15. Breast Cancer Res. 2002. PMID: 12100736 Free PMC article.

3

Adjuvant endocrine therapy in postmenopausal breast cancer.

Ingle JN. Ingle JN. Clin Cancer Res. 2003 Jan;9(1 Pt 2):480S-5S. Clin Cancer Res. 2003. PMID: 12538504 Review.

4

Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings.

Ingle JN, Suman VJ. Ingle JN, et al. J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):313-9. doi: 10.1016/s0960-0760(03)00373-x. J Steroid Biochem Mol Biol. 2003. PMID: 14623527 Review.

5

Sequencing of endocrine therapy in postmenopausal women with advanced breast cancer.

Ingle JN. Ingle JN. Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):362S-7S. doi: 10.1158/1078-0432.ccr-031200. Clin Cancer Res. 2004. PMID: 14734492

6

Effects of exemestane and tamoxifen in a postmenopausal breast cancer model.

Jelovac D, Macedo L, Handratta V, Long BJ, Goloubeva OG, Ingle JN, Brodie AM. Jelovac D, et al. Among authors: ingle jn. Clin Cancer Res. 2004 Nov 1;10(21):7375-81. doi: 10.1158/1078-0432.CCR-04-0565. Clin Cancer Res. 2004. PMID: 15534114

7

Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settings.

Ingle JN. Ingle JN. Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):900s-5s. Clin Cancer Res. 2005. PMID: 15701884 Review.

8

Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozole.

Lafky JM, Baron AT, Cora EM, Hillman DW, Suman VJ, Perez EA, Ingle JN, Maihle NJ. Lafky JM, et al. Among authors: ingle jn. Cancer Res. 2005 Apr 15;65(8):3059-62. doi: 10.1158/0008-5472.CAN-05-0067. Cancer Res. 2005. PMID: 15833834

9

Aromatase inhibitors for therapy of advanced breast cancer.

Ingle JN, Suman VJ. Ingle JN, et al. J Steroid Biochem Mol Biol. 2005 May;95(1-5):113-9. doi: 10.1016/j.jsbmb.2005.04.014. J Steroid Biochem Mol Biol. 2005. PMID: 15939585

10

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.

Goetz MP, Rae JM, Suman VJ, Safgren SL, Ames MM, Visscher DW, Reynolds C, Couch FJ, Lingle WL, Flockhart DA, Desta Z, Perez EA, Ingle JN. Goetz MP, et al. Among authors: ingle jn. J Clin Oncol. 2005 Dec 20;23(36):9312-8. doi: 10.1200/JCO.2005.03.3266. J Clin Oncol. 2005. PMID: 16361630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

423 results

Search Page